sulfamethoxazole has been researched along with Leukemia, Myeloid in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watson, JG | 1 |
| Jameson, B | 1 |
| Powles, RL | 1 |
| McElwain, TJ | 1 |
| Lawson, DN | 1 |
| Judson, I | 1 |
| Morgenstern, GR | 1 |
| Lumley, H | 1 |
| Kay, HE | 1 |
1 trial available for sulfamethoxazole and Leukemia, Myeloid
| Article | Year |
|---|---|
Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia.
Topics: Acute Disease; Anti-Bacterial Agents; Bone Marrow Transplantation; Clinical Trials as Topic; Colisti | 1982 |